CORDIS Simple search


Choose your language:
en

Contextual menu:

Path:


Menu
  :: About Projects  


Generation of broadly cross neutralising Antibodies for innovative active-passive HIV Vaccination Strategies based on modified Ig-gene transgenic mice

Start date:2005-12-01

End date:2008-11-30

Project Acronym:HIVAB

Project status:Completed

Coordinator

Organization name:UNIVERSITY OF REGENSBURG
Administrative contact Address
Name:Hans Ralf WOLF / WAGNER (Professor) INSTITUTE FOR MEDICAL MICROBIOLOGY AND HYGIENE (RIMMH)
INSTITUTE FOR IMMUNOLOGY (URII), PROF. THOMAS HEHLGANS, PHONE: +49 941 944 6626
Franz-Josef-Strauss-Allee 11

REGENSBURG
DEUTSCHLAND

Region:BAYERN OBERPFALZ Regensburg, Landkreis
Tel:+49-9419446400
Fax:+49-9419446402
E-mail:Contact
URL: Organization Type:

Description


Objective: For improved protection from HIV infection during birth or through accidental exposure to HIV, antibodies with broad neutralizing activity would be a valuable addition to antiretroviral treatment and to vaccines. So far in the field of HIV applied resear ch only few antibodies with broad cross clade neutralizing properties are available (b12, 2G12, 2F5 and 4E10). They recognize either epitopes presented only transiently during infection of cells, or epitopes not recognizable by unmodified immunoglobulins (2G12). Two experimental strategies are used in separate and in combination. One uses the lead given by extremely rare mutant antibody genes (ie 2G12) to generate mice with germ line modified immunoglobulin genes which introduce extended mobility into th e immunoglobulin protein backbone. Immunisation of these mice will allow recognition of novel expanded epitopes including glycane clusters and the development of monoclonal antibody. The other line of experiments employs HIV receptor-transgenic mice for i mmunization to favour receptor mediated transitory stages of the viral envelope. Previous experience and reagents from earlier EU funded programmes (virosome incorporating HIV proteins PN 012183) and new microbicide-vaccine combinations against HIV (subm. call LSH-2004-2.3.0-1 with R. Shattock) to present native oligomeric HIV envelope of clinically relevant HIV isolates will be used in addition to liposome presented recombinant C-clade gp 140 oligomers and gp160 encoding highly effective DNA plasmid vacc ines in CD4 transgenic mice to generate monoclonal antibodies with novel broadly neutralizing properties. This proof of principle can directly give valuable reagents. It can also be further developed into humanized antibodies. The novel antibodies develo ped out of this programme will be valuable additions to the immunogens developed by the EUROVAC group in the context of FP5. The C-clade chosen is of major importance in the worldwide HIV epidemic.

Achievements:

General information:

Project Details


Start date:2005-12-01

End date:2008-11-30

Duration:36 months

Project Reference:19052

Project cost:1051750 EURO

Project Funding:950000 EURO

Programme Acronym: FP6-LIFESCIHEALTH

Programme type:Sixth Framework Programme

Subprogramme Area:Research in poverty-related diseases by SMEs

Contract type:Specific Targeted Research Project

URL:

Subject index:Biotechnology, Life Sciences, Scientific Research, Medicine, Health
 

Other participants

Organization name:POLYMUN SCIENTIFIC GMBH
Administrative contact Address
Name:Hermann KATINGER (Professor) POLYMUN
Nussdorfer Laende 11

VIENNA
ÖSTERREICH

Region:OSTÖSTERREICH WIEN
Tel:+43-1360066202
Fax:+43-13697615
E-mail:Contact
URL:http://www.polymun.com Organization Type:Industry
 
Organization name:THE IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Administrative contact Address
Name:Simon Alexander JEFFS (Dr) DIVISION OF MEDICINE
Exhibition Road

LONDON
UNITED KINGDOM

Region:SOUTH EAST (UK) GREATER LONDON
Tel:+44-2075943918
Fax:+44-2075943906
E-mail:Contact
URL:http://www.ic.ac.uk Organization Type:Education
 
Organization name:UNIVERSITY OF NATURAL RESOURCES & APPLIED LIFE SCIENCES VIENNA
Administrative contact Address
Name:Renate KUNERT (Professor) IAM
Gregor-Mendel-Straße 33

VIENNA
ÖSTERREICH

Region:OSTÖSTERREICH WIEN
Tel:+43-360066595
Fax:+43-13697615
E-mail:Contact
URL:http://www.boku.ac.at Organization Type:
 
Organization name:GENEART AG
Administrative contact Address
Name:Frank NOTKA (Dr) GENEART GMBH
Josef-Engert-Strasse 9

REGENSBURG
DEUTSCHLAND

Region:BAYERN OBERPFALZ Regensburg, Landkreis
Tel:+49-9419427645
Fax:+49-9419427611
E-mail:Contact
URL:http://www.geneart.de Organization Type:Industry
 

Record control number:78573




CORDIS is managed by the Publications Office